Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
Dive into the research topics where David Wei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
Podcyta Exact Morphology Measurement Procedure (PEMP)
Wei, D. (PI)
Sealy and Smith Foundation ( Award # )
2/19/25 → 2/18/29
Project: Research project
-
Viral-immune interaction in glomerular kidney disease
Wei, D. (PI)
National Institute of Diabetes and Digestive and Kidney Diseases ( Award #1R01DK13805501)
5/1/24 → 2/28/29
Project: Research project
-
suPAR and renal fibrosis
Wei, D. (PI)
National Institute of Diabetes and Digestive and Kidney Diseases ( Award #5R01DK12585806)
2/1/24 → 4/30/26
Project: Research project
-
Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders
Altintas, M. M., Agarwal, S., Sudhini, Y., Zhu, K., Wei, C. & Reiser, J., Jan 24 2025, In: Annual Review of Pathology: Mechanisms of Disease. 20, 1, p. 329-353 25 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)
Chu, J., Tung, L., Atallah, I., Wei, C., Cobleigh, M., Rao, R., Feinstein, S. B., Usha, L., Banach, K., Reiser, J. & Okwuosa, T. M., Feb 6 2024, In: Cardio-Oncology. 10, 1, p. 5Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study
Chu, J., Tung, L., Attalah, I., Wei, C., Cobleigh, M., Rao, R., Feinstein, S. B., Usha, L., Banach, K., Reiser, J. & Okwuosa, T. M., Jan 15 2024, In: Cardio-Oncology. 10, 1, p. 3 3.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
Toronto Glomerulonephritis Registry Group, Nov 2023, In: Kidney International Reports. 8, 11, p. 2403-2415 13 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure: SuPAR in Heart Failure
Hayek, S. S., Tahhan, A. S., Ko, Y. A., Alkhoder, A., Zheng, S., Bhimani, R., Hartsfield, J., Kim, J., Wilson, P., Shaw, L., Wei, C., Reiser, J. & Quyyumi, A. A., Feb 2023, In: Journal of Cardiac Failure. 29, 2, p. 158-167 10 p.Research output: Contribution to journal › Article › peer-review
22 Scopus citations